Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 3 | Vintage Vibes

3 Lucrative Biotech Stock Buys for Success

The development of orphan medications, innovative biotech equipment, personalized medicine, and strong government support are all contributing to the biotech industry's upward trajectory. Thus, lucrative biotech stocks Vertex Pharmaceuticals (VRTX), Innoviva (INVA), and Organogenesis Holdings (ORGO) could be ideal additions to your portfolio right now. Read more….

StockNews.com

3 Iron Condor Trade Ideas For January 5th

Volatility is on the rise which could mean it’s a good time to be on look lookout for Iron Condor trades.

Barchart

4 A-Rated Biotech Stock Picks for 2024 Success

The biotechnology industry is experiencing significant growth, fueled by recent breakthroughs in drug development, technological innovations, and robust government support. Given this backdrop, promising biotech stocks Shionogi & Co. (SGIOY), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and United Therapeutics Corporation (UTHR) could be solid buys for 2024 success. Also, these…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stock Buys to Supercharge Your Portfolio

The biotechnology industry is flourishing due to the recent breakthroughs in drug development, technological advancements, and strong governmental backing. Given this backdrop, promising biotech stocks Organogenesis Holdings (ORGO), Theratechnologies (THTX), and Vertex Pharmaceuticals (VRTX) could be solid buys to supercharge the portfolios. Read on….

StockNews.com

Top 3 Biotech Stocks for Weekly End-of-Year Profits

In the ever-evolving realm of biotechnology, technological advancements and breakthroughs are propelling significant growth. Hence, fundamentally strong biotech stocks Equillium (EQ), United Therapeutics (UTHR), and Vertex Pharmaceuticals (VRTX) might be solid investments for weekly year-end gains. Read more….

StockNews.com

3 Safe Biotech Stocks to Buy This Week

Given enhanced healthcare spending, the growing frequency of chronic diseases, government support, and rapid digital transformation, the biotech industry appears to have favorable prospects. Therefore, fundamentally strong biotech stocks Vertex Pharmaceuticals (VRTX), Innoviva (INVA), and Acorda Therapeutics, Inc. (ACOR) could be ideal additions to your portfolio this week. Read more….

StockNews.com

3 Biotech Stocks Beating BioMarin Pharmaceutical (BMRN)

Breakthrough developments, the use of advanced technologies, and rising investments in R&D are some of the factors driving the growth of the biotech industry. Although BioMarin Pharmaceutical (BMRN) showcases strong growth prospects, investors could consider buying even better biotech stocks Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and Vertex Pharmaceuticals (VRTX). Read…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Vertex Pharmaceuticals (VRTX) Post-Earnings Analysis: Is It Time to Buy the Stock?

After a solid third-quarter earnings report, does Vertex Pharmaceuticals (VRTX) deserve a place in your portfolio? Let’s look at its financial metrics to gauge its prospects….

StockNews.com

4 Promising Biotech Stocks for Smart Investment Strategies

The biotechnology industry is flourishing due to the recent strides in drug formulation, technological advancements, and unwavering government support. Given this backdrop, promising biotech stocks United Therapeutics (UTHR), Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD) present smart investment options to garner significant returns. Read on….

StockNews.com

3 Best Biotech Stocks for Health and Wealth

With medical innovations and technological breakthroughs rapidly transforming the healthcare landscape, biotech stocks have garnered unprecedented attention in the investment community. Thus, fundamentally robust stocks like Incyte Corp. (INCY), Vertex Pharmaceuticals (VRTX), and Amgen (AMGN) could contribute to the health and wealth of your portfolios. Read more….

StockNews.com

3 Biotech Stocks With Strong Value in August

The biotech industry is ascending with growing R&D initiatives, an upsurge in personalized medicine, and enhanced drug formulations, coupled with the incorporation of technological advancements. So, it seems wise to invest in discounted biotech stocks Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Alkermes (ALKS) this month. Keep reading….

StockNews.com

3 Biotech Stocks With 'A' POWR Ratings

The biotech industry is poised for significant growth due to the rising orphan drug formulations and the adoption of emerging technologies. Therefore, fundamentally strong biotech stocks Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and United Therapeutics (UTHR) might be solid buys. These stocks are A (Strong Buy) rated in our proprietary…

StockNews.com

3 Momentum Stocks to Buy Now

The market remains volatile amid macroeconomic pressures and fears of an impending recession. However, fundamentally strong stocks Vertex Pharmaceuticals (VRTX), US Foods Holding (USFD), and Vontier (VNT) have gained momentum and could be worth buying. Keep reading.

StockNews.com

3 Stocks That'll Survive Any Recession

Market experts continue to fear that higher interest rates from the Federal Reserve and the potential for a credit crunch might tip the economy into a recession. Given this backdrop, quality stocks Oracle Corp. (ORCL), Vertex Pharmaceuticals (VRTX), and Humana (HUM) have solid fundamentals that could help them survive a…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 of the Best Stocks in 1 of Wall Street's Worst-Rated Industry

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…

StockNews.com

4 Biotech Stocks You Don’t Want to Miss out on in 2023

The biotech industry is growing with considerable developments and government initiatives. Given the solid prospects of the industry, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Exelixis (EXEL), and Cidara Therapeutics (CDTX) could be excellent buys. Keep reading.

StockNews.com

2 Biotech Stocks to Buy Hand Over Fist in March

The biotech industry is expected to expand rapidly, driven by significant advancements and government initiatives. Furthermore, this sector tends to be relatively defensive and holds up relatively well during downturns. So, fundamentally sound biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) might be ideal buys now. Keep reading.

StockNews.com

3 Nasdaq Stocks That Could Carry Your Portfolio for Years

With the broader market in trepidation amid the ongoing turmoil in the banking sector, fundamentally strong and resilient Nasdaq stocks Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and Autodesk (ADSK) could be worth investing in for sustained risk-adjusted returns. Continue reading….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

2 Bargain Stocks to Buy For 2023 And Beyond

Despite widespread headwinds, experts believe the U.S. economy might avoid a recession this year. Additionally, value stocks have been outperforming growth, and we think Vertex Pharmaceuticals (VRTX) and Kroger (KR), which seem to be trading at discounts, could be ideal buys for 2023 and beyond. Keep reading.

StockNews.com

5 Biotech Stocks That Could Make You Rich in 10 Years

The biotech industry is rapidly growing amid rising private and government investments and technological advancements. Given the solid prospects of the industry, fundamentally strong biotech stocks Amgen (AMGN), Vertex (VRTX), United Therapeutics (UTHR), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) might be ideal long-term investments for steady returns. Keep reading.

StockNews.com

The 5 Best Stocks to Invest $1,000 in Right Now

Improving investors’ sentiments amid the cooling inflation and moderating interest rate increases helped the stock market to surge in recent weeks. Moreover, the IMF raised its world economy growth forecast. Given the rising optimism, AbbVie (ABBV), Vertex Pharmaceuticals (VRTX), Murphy (MUSA), MasterCraft Boat (MCFT), and PrimeEnergy Resources (PNRG) might be…

StockNews.com

3 Biotech Stocks to Get in on Before It’s Too Late

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

StockNews.com

The No. 1 Biotech Stock to Buy for 2023

Biotech stock Vertex Pharmaceuticals (VRTX) outperformed its industry peers, gaining more than 30% over the past year. The company reported solid performance in the CF business and across the company in the last quarter. Moreover, VRTX is committed to delivering a diversified pipeline of transformative medicines and therapies. Hence, this…

StockNews.com

3 Biotech Stocks to Help Boost Your Portfolio in January

Increased government initiatives and the rising adoption of biotechnology in healthcare and agriculture are likely to enhance the growth of the biotech industry. Hence, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal additions to your portfolio as they look well-positioned to capitalize…

StockNews.com

3 Biotech Stocks to Buy Before December and 1 to Sell

The biotech industry is increasingly gaining prominence due to the growing prevalence of chronic disease and advancements in drug discovery and development. Given the industry’s solid growth prospects, it could be wise to buy quality biotech stocks, Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and United Therapeutics (UTHR). However, we think…

1 2 3 4 5

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

International Monetary Fund

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.